Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration by Khanani AM

Get full text

Cooling Anesthesia for Intravitreal Injections – A Review by Chandrasekaran PR, Aziz AA, Khan H, Khanani AM

Get full text

Macular Telangiectasia Type 2: A Comprehensive Review by Kedarisetti KC, Narayanan R, Stewart MW, Reddy Gurram N, Khanani AM

Get full text

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better by Khanani AM, Gahn GM, Koci MM, Dang JM, Brown SM, Hill LF

Get full text

Angiopoietins as Potential Targets in Management of Retinal Disease by Khanani AM, Russell MW, Aziz AA, Danzig CJ, Weng CY, Eichenbaum DA, Singh RP

Get full text

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study) by Drenser KA, Pieramici DJ, Gunn JM, Rosberger DF, Kozma P, Fineman MS, Duchateau L, Khanani AM

Get full text

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials by Singer M, Liu M, Schlottmann PG, Khanani AM, Hemphill M, Hill L, Tuomi L, Haskova Z

Get full text

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration by Khan H, Aziz AA, Sulahria H, Khan H, Ahmed A, Choudhry N, Narayanan R, Danzig C, Khanani AM

Get full text

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results by Callanan D, Khurana RN, Maturi RK, Patel S, Wykoff CC, Eichenbaum D, Khanani AM, Hassan T, Badger H, Mehta S, Le G, Attar M, Seal J, Li XY

Get full text